{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:41:04Z","timestamp":1792741264143,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/inf.0b013e3181faa6be","type":"journal-article","created":{"date-parts":[[2010,10,5]],"date-time":"2010-10-05T05:18:59Z","timestamp":1286255939000},"page":"e80-e90","source":"Crossref","is-referenced-by-count":116,"title":["Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age"],"prefix":"10.1097","volume":"29","author":[{"given":"Matthew D.","family":"Snape","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaam L.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis D.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llinos","family":"Rollinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pestridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Galiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherryl A.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ly-Mee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio A.","family":"Emini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-31-20210202","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"R3-31-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-31-20210202","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"R6-31-20210202","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"R8-31-20210202","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children\u2014Advisory Committee on Immunization Practices (ACIP).","volume":"59","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"R9-31-20210202","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.2009-1405","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.","volume":"125","author":"Bryant","year":"2010","journal-title":"Pediatrics"},{"key":"R12-31-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R13-31-20210202","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"147","author":"Kayhty","year":"1983","journal-title":"J Infect Dis"},{"key":"R14-31-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1081\/IMM-100105064","article-title":"A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides.","volume":"30","author":"Quataert","year":"2001","journal-title":"Immunol Invest"},{"key":"R15-31-20210202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R16-31-20210202","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CDLI.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.","volume":"2","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"R18-31-20210202","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"R19-31-20210202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement o functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R20-31-20210202","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/CDLI.12.2.287-295.2005","article-title":"Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.","volume":"12","author":"Hu","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R21-31-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R22-31-20210202","article-title":"Recommendations for the Production and Control of Pneumococcal Conjugate Vaccines.","year":"2005"},{"key":"R23-31-20210202","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":"Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.","volume":"25","author":"Henckaerts","year":"2007","journal-title":"Vaccine"},{"key":"R24-31-20210202","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"R25-31-20210202","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-4475-7","article-title":"Modelling Binary Data.","author":"Collett","year":"1991"},{"key":"R26-31-20210202","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.0006-341X.1999.01202.x","article-title":"Test-based exact confidence intervals for the difference of two binomial proportions.","volume":"55","author":"Chan","year":"1999","journal-title":"Biometrics"},{"key":"R27-31-20210202","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/IAI.69.4.2378-2382.2001","article-title":"Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.","volume":"69","author":"Richmond","year":"2001","journal-title":"Infect Immun"},{"key":"R28-31-20210202","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom.","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"key":"R31-31-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0b013e3181c67f04","article-title":"Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom.","volume":"29","author":"Goldblatt","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R32-31-20210202","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.vaccine.2009.03.087","article-title":"Challenges in the evaluation and licensing of new pneumococcal vaccines, 7\u20138 July 2008, Ottawa, Canada.","volume":"27","author":"Feavers","year":"2009","journal-title":"Vaccine"},{"key":"R34-31-20210202","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Differential effects of pneumococcal vaccines against serotypes 6A and 6C.","volume":"198","author":"Park","year":"2008","journal-title":"J Infect Dis"},{"key":"R35-31-20210202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine compared to 7-valent pneumococcal conjugate vaccine given as a 3-dose series with routine vaccines in healthy infants and toddlers.","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R36-31-20210202","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1016\/j.vaccine.2010.04.008","article-title":"Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany.","volume":"28","author":"Kieninger","year":"2010","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201012000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:38:46Z","timestamp":1786041526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201012000-00031"}},"subtitle":["A Double-blind Randomized Active-controlled Trial"],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181faa6be","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}